Rate limiting enzyme in fatty acid synthesis ?
The rate-limiting enzyme is typically the one that controls the overall speed of the pathway. In fatty acid synthesis, the first committed step is the formation of malonyl-CoA from acetyl-CoA. That reaction is catalyzed by acetyl-CoA carboxylase (ACC). So ACC is the rate-limiting enzyme because it's the first step that commits acetyl-CoA to the fatty acid synthesis pathway. It requires biotin as a cofactor and is regulated by various factors like citrate, which activates it, and palmitoyl-CoA, which inhibits it.
Now, the options given are A to D, but the user didn't list them. However, common distractors for this question might include enzymes like HMG-CoA reductase (involved in cholesterol synthesis), fatty acid synthase itself, or maybe others like pyruvate carboxylase. Let's think: HMG-CoA reductase is the rate-limiting enzyme in cholesterol synthesis, so if that's an option, it's incorrect here. Fatty acid synthase is the complex that carries out the synthesis steps, but the rate-limiting step is before that, at ACC. Other options could be enzymes from other pathways, like pyruvate dehydrogenase or something else.
So, the correct answer is acetyl-CoA carboxylase. The clinical pearl here is that ACC is a target for drugs like thiazolidinediones, which are PPAR-gamma agonists used in diabetes. Also, statins target HMG-CoA reductase, which is a common confusion point. Students might mix up the enzymes for fatty acid vs. cholesterol synthesis. So the key is to remember that ACC is the first step in fatty acid synthesis, making it the rate-limiting enzyme.
**Core Concept**
Fatty acid synthesis is initiated by acetyl-CoA carboxylase (ACC), which catalyzes the irreversible conversion of acetyl-CoA to malonyl-CoA. This step is the **rate-limiting** and **committed** step of de novo fatty acid synthesis, regulated by allosteric effectors and phosphorylation.
**Why the Correct Answer is Right**
Acetyl-CoA carboxylase (ACC) is the rate-limiting enzyme because it commits acetyl-CoA to the fatty acid synthesis pathway. It requires biotin as a cofactor and is activated by citrate while inhibited by palmitoyl-CoA. ACC exists in two isoforms (ACC1 in liver and adipose, ACC2 in muscle), with ACC1 primarily regulating fatty acid synthesis. Inhibition of ACC reduces malonyl-CoA, decreasing fatty acid production and increasing fatty acid oxidation via AMPK activation.
**Why Each Wrong Option is Incorrect**
**Option A:** *HMG-CoA reductase* is the rate-limiting enzyme in cholesterol synthesis (not fatty acids).
**Option B:** *Fatty acid synthase* is the multi-enzyme complex